Synthesis of the extracellular domain of GLP-1R by chemical and biotechnological approaches
The extracellular domain of the glucagon-like peptide-1 receptor, GLP-1R, is responsible for the binding of GLP-1, and a handful of additional agonists (such as exenatide, lixisenatide, and liraglutide) used daily for treating type II diabetes mellitus. Lead discovery and optimization, however, requ...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2022
|
| Sorozat: | RSC ADVANCES
12 No. 37 |
| Tárgyszavak: | |
| doi: | 10.1039/D2RA02784D |
| mtmt: | 33071352 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/26479 |